ClinicalTrials.gg
Sign In
Drug

Pittsburgh compound B clinical trials

studies test it
16
open now
4
in phase 3
0
first study started
2008

How each study uses Pittsburgh compound B is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pittsburgh compound B studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

11C-PIB
5
Pittsburgh Compound B
4
C-11 PiB
4
C11 Pittsburgh Compound B
2

Studies by the year they started

16 studies that test it; most in 2012 (3)

Studies that test Pittsburgh compound B, by start year
YearStudies
20081
20101
20123
20131
20141
20161
20171
20181
20192
20203
20231

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
7
Phase 2
4
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Alzheimer Disease
7
Parkinson Disease
2
Brain Concussion
1
Primary Progressive Nonfluent Aphasia
1
Aphasia
1
Multiple Sclerosis
1
Dementia
1

Who runs them

Industry 1 · Other 15

Mayo Clinic (7) · University of North Carolina, Chapel Hill (1) · Vanderbilt University Medical Center (1) · University of Pittsburgh (1) · Johns Hopkins University (1) · Avid Radiopharmaceuticals (1) · Peking Union Medical College Hospital (1) · National Institute of Mental Health (NIMH) (1)

Often tested with

Tested in the same studies.

PIB C-11 (3) · Florbetapir (1) · Flortaucipir (1) · ER-176 C-11 (1) · Florquinitau F-18 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Pittsburgh compound B.

Studies

Open first, then newest update. How each study uses Pittsburgh compound B is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Given beside what is tested · 1 — Pittsburgh compound B is usual care or a partner of the new treatment